Impact of comorbidity indexes on non-relapse mortality

Leukemia

Volumn 22, Issue 11, 2008, Pages 2062-2069

  Xhaard, A ^a   Porcher, R ^b,c   Chien, J W ^d   de Latour, R P ^a,c   Robin, M ^a   Ribaud, P ^a   Rocha, V ^a   Devergie, A ^a   Ferry, C ^a   Martin, P J ^d   Socie G ^a,c  

^a SAINT LOUIS HOSPITAL   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c INSERM   (France)

^d Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; FLUDARABINE; MYELOABLATIVE AGENT;

ADOLESCENT; ADULT; AGE; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DISCRIMINANT ANALYSIS; DISEASE ASSOCIATION; DONOR SELECTION; FANCONI ANEMIA; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LIVER DISEASE; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MORTALITY; OVERALL SURVIVAL; PATIENT COUNSELING; PREDICTION; PRIORITY JOURNAL; RELAPSE; RETROSPECTIVE STUDY; SCORING SYSTEM;

EID: 56249119849     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2008.197     Document Type: Article

References (17)

1. Bacigalupo A, Sormani MP, Lamparelli T, Gualandi F, Occhini D, Bregante S et al. Reducing transplant-related mortality after allogeneic hematopoietic stem cell transplantation. Haematologica 2004; 89 1238-1247.
2. Artz AS, Pollyea DA, Kocherginsky M, Stock W, Rich E, Odenike O et al Performance status and comorbidity predict transplant-related mortality after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2006; 12: 954-964.
3. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987; 40: 373-383.
4. Extermann M. Measurement and impact of comorbidity in older cancer patients. Crit Rev Oncol Hemato 2000; 35: 181-200.
5. Bolwell BJ. Are predictive factors clinically useful in bone marrow transplantation? Bone Marrow Transplant 2003; 32: 853-861.
6. Alamo J, Shahjahan M, Lazarus HM, de Lima M, Giralt SA. Comorbidity indices in hematopoietic stem cell transplantation: A new report card. Bone Marrow Transplant 2005; 36: 475-479.
7. de Groot V, Beckerman H, Lankhorst GJ, Bouter LM. How to measure comorbidity. A critical review of available methods. J Clin Epidemiol 2003; 56: 221-229.
8. Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol 1994; 47: 1245-1251.
9. Diaconescu R, Flowers CR, Storer B, Sorror ML, Maris MB, Maloney DG et al. Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors. Blood 2004; 104: 1550-1558.
10. Sorror ML, Maris MB, Storer B, Sandmaier BM, Diaconescu R, Flowers C et al. Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: Influence of pretransplantation comorbidities. Blood 2004; 104: 961-968.
11. Shahjahan M, Alamo J, de Lima M, Khouri I, Gajewski J, Andersson B et al. Effect of comorbidities on allogeneic hematopoietic stem cell transplant outcomes in AML/MDS patients in first complete remission. Biol Blood Marrow Transplant 2004; 10 (Suppl 1): S12-S13.
12. Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, Maloney DG et al Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 2005; 106: 2912-2919.
13. Parimon T, Au DH, Martin PJ, Chien JW. A risk score for mortality after allogeneic hematopoietic cell transplantation. Ann Intern Med 2006; 144: 407-414.
14. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. John Wiley & Sons: New York (NY), 1980, pp 163-178.
15. Harrell Jr FE, Lee KL, Califf RM, Pryor DB, Rosati RA. Regression modelling strategies for improved prognostic prediction. Stat Med 1984; 3: 143-152.
16. Harrell Jr FE. Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression and Survival Analysis. Springer-Verlag: New York (NY), 2001, pp 249-253.
17. Sorror ML, Giralt S, Sandmaier BM, De Lima M, Shahjahan M, Maloney DG et al. Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: Combined FHCRC and MDACC experiences. Blood 2007; 10: 4606-4613.